These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30790103)

  • 1. The impact of repetitive oocyte retrieval on the ovarian reserve: a retrospective cohort study.
    Marschalek J; Ott J; Aitzetmueller M; Mayrhofer D; Weghofer A; Nouri K; Walch K
    Arch Gynecol Obstet; 2019 May; 299(5):1495-1500. PubMed ID: 30790103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
    Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of AMH on IVF success.
    Gomez R; Schorsch M; Hahn T; Henke A; Hoffmann I; Seufert R; Skala C
    Arch Gynecol Obstet; 2016 Mar; 293(3):667-73. PubMed ID: 26449238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
    Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle.
    Liu X; Han Y; Wang X; Zhang Y; Du A; Yao R; Lv J; Luo H
    BMC Pregnancy Childbirth; 2022 Apr; 22(1):279. PubMed ID: 35366830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?
    Inal ZO; Engin Ustun Y; Yilmaz N; Aktulay A; Bardakci Y; Gulerman C
    J Obstet Gynaecol; 2019 May; 39(4):516-521. PubMed ID: 30744464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.
    Lin PY; Huang FJ; Kung FT; Chiang HJ; Lin YJ; Lin YC; Lan KC
    Int J Clin Exp Pathol; 2014; 7(9):6245-53. PubMed ID: 25337276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
    Guo Y; Liu S; Hu S; Li F; Jin L
    Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of serum Anti-Mullerian Hormone levels on the results of assisted reproductive technologies. Single-center retrospective study from 2011 cycles (ICSI and bilateral tubal obstruction excluded)].
    Dosso N; Robin G; Catteau-Jonard S; Pigny P; Leroy-Billiard M; Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2015 Jan; 44(1):63-71. PubMed ID: 24951378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology.
    Tal R; Seifer CM; Khanimov M; Seifer DB; Tal O
    Reprod Biol Endocrinol; 2020 Mar; 18(1):20. PubMed ID: 32156287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age, body weight and ovarian function affect oocyte size and morphology in non-PCOS patients undergoing intracytoplasmic sperm injection (ICSI).
    Weghofer A; Kushnir VA; Darmon SK; Jafri H; Lazzaroni-Tealdi E; Zhang L; Albertini DF; Barad DH; Gleicher N
    PLoS One; 2019; 14(10):e0222390. PubMed ID: 31647816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of anti-Mullerian hormone levels in serum and follicle fluid for IVF-ET outcomes in patients with polycystic ovarian syndrome].
    Chen X; Yin M; Ye D; He Y; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):546-9. PubMed ID: 23644117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes and correlations of anti-Müllerian hormone and stem-cell factors in different ovarian reserve patients during GnRH-antagonist protocol and the effects on controlled ovarian hyperstimulation outcomes.
    Liu XH; Wu XH; Yang S
    Arch Gynecol Obstet; 2019 Dec; 300(6):1773-1783. PubMed ID: 31631249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K; Zander-Fox D
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can AMH levels predict the need for increased medication during IVF/ICSI in PCOS women?
    Kamel A; Ramadan W; Hussein AM; Dahab S; Elsherbini MM; Lasheen YS; Abu-Hamila F
    J Matern Fetal Neonatal Med; 2018 Jan; 31(1):32-38. PubMed ID: 27978775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the likely IVF/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study.
    Daney de Marcillac F; Pinton A; Guillaume A; Sagot P; Pirrello O; Rongieres C
    J Gynecol Obstet Hum Reprod; 2017 Oct; 46(8):629-635. PubMed ID: 28843783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.